CARLOS
MACAYA MIGUEL
Profesor emérito
Hospital Universitario La Paz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario La Paz (36)
2022
-
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry
Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136
-
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry
International Journal of Clinical Practice, Vol. 2022
-
Design and Rationale for a Real-World Prospective, Multicenter Registry of Myocardial Revascularization Failure and Secondary Revascularization: The REVASEC Study
Cardiovascular Revascularization Medicine, Vol. 40, pp. 50-56
-
Predictors of poor prognosis in healthy, young, individuals with SARS-CoV-2 infections
Clinical Microbiology and Infection, Vol. 28, Núm. 2, pp. 273-278
-
Vascular healing responses to paclitaxel coated balloons or everolimus eluting stents for the treatment of in-stent restenosis. Insights from optical coherence tomography
Coronary Artery Disease, Vol. 33, Núm. 8, pp. 609-617
2021
-
Atrial fibrillation in patients with COVID-19. Usefulness of the CHA2DS2-VASc score: an analysis of the international HOPE COVID-19 registry
Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 608-615
-
Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19
Age and ageing, Vol. 50, Núm. 2, pp. 326-334
-
Does there exist an obesity paradox in COVID-19? Insights of the international HOPE-COVID-19-registry
Obesity Research and Clinical Practice, Vol. 15, Núm. 3, pp. 275-280
-
Gender Differences in the Presentation and Outcomes of Hospitalized Patients With COVID-19
Journal of hospital medicine, Vol. 16, Núm. 6, pp. 349-352
-
Impact of smoking on COVID-19 outcomes: A HOPE Registry subanalysis
BMJ Nutrition, Prevention and Health, Vol. 4, Núm. 1, pp. 285-292
-
Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis
Revista Espanola de Cardiologia, Vol. 74, Núm. 5, pp. 427-435
-
Non-invasive ventilation for SARS-CoV-2 acute respiratory failure: A subanalysis from the HOPE COVID-19 registry
Emergency Medicine Journal, Vol. 38, Núm. 5, pp. 359-365
-
Prevalence and 30-Day Mortality in Hospitalized Patients With Covid-19 and Prior Lung Diseases
Archivos de Bronconeumologia, Vol. 57, pp. 13-20
-
Renin-angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: Final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry
American Heart Journal, Vol. 237, pp. 104-115
-
Thin- versus thick-strut polymer-free biolimus-eluting stents: The BioFreedom QCA randomised trial
EuroIntervention, Vol. 17, Núm. 3, pp. 233-239
-
Underlying heart diseases and acute covid-19 outcomes
Cardiology Journal, Vol. 28, Núm. 2, pp. 202-214
2020
2018
-
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents
JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991
2015
-
A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients with In-Stent Restenosis of Drug-Eluting Stents the RIBS IV Randomized Clinical Trial
Journal of the American College of Cardiology, Vol. 66, Núm. 1, pp. 23-33
-
Incidence, management, and immediate- and long-term outcomes after iatrogenic aortic dissection during diagnostic or interventional coronary procedures
Circulation, Vol. 131, Núm. 24, pp. 2114-2119